Antimicrobial Agents and Chemotherapy, November 1998, p. 3050-3050, Vol. 42, No. 11
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Revised Sequence of OtrB (Tet347) Tetracycline Efflux
Protein from Streptomyces rimosus
The sequence of the tetracycline resistance gene designated
tet347 from the tetracycline-producing organism
Streptomyces rimosus (strain PG3) predicted a protein of 347 amino acids (6) (GenBank accession no. M20370). The
tcrC gene (also called tcr3; GenBank accession
no. D38215) from chlorotetracycline-producing S. aureofaciens encoded a 512-residue putative tetracycline efflux protein which, starting at residue 222, was 43% identical to the Tet347 protein (3). Whether tetB, an S. rimosus gene proven to encode tetracycline efflux (5),
is the same as tet347 is unclear (1, 6). The
Tet347 protein was predicted to have 7.5 transmembrane helices, and
TcrC was predicted to have 14 (TopPred2 software program
[2]) (unpublished data). Because even eight transmembrane helices would be unusual for a tetracycline efflux protein, we have resequenced tet347 (on plasmid pUT1954
[6]) from nucleotide (nt) 110 to near the end of the
cloned region at nt 2054 (sequencing was performed at the Tufts Core
Facility with PCR cycling/dye terminator and an Applied Biosystems 373 DNA Stretch Sequencer). Sequences were obtained for both strands between nt 110 and 787; overlapping forward sequence was obtained for
nt 620 to 1250, 1100 to 1650, and 1590 to 2000. The most serious of the
various errors we found in the previous sequence were located upstream
of nt 787 and had led to misinterpretation of the open reading frame.
Our new sequence shows 216 additional amino acids at the amino terminus
of the protein and reidentifies 4 internal amino acids.
Our revised open reading frame begins not at nt 797 but at nt 149 (numbering according to reference 6, with GTG as the translation start codon [see below]). The revised open reading frame
ends at nt 1837, in agreement with the earlier study (6). The sequence immediately upstream from the GTG codon is
AGGAGAGTGAGGAACC (candidates for
Shine-Dalgarno sequences are underlined). The revised sequence
specifies a protein of 563 residues, with 14 transmembrane helices
predicted by TopPred2. Amino acid residues 12 to 465 of the Tet347
revised sequence are 65% identical to those of a corresponding region
in TcrC (Bestfit program of the Genetics Computer Group). TopPred2
hydropathy plots for these two proteins differ principally in the
region following putative transmembrane helix 13. As is true for all
other tetracycline efflux proteins (4), both TcrC and Tet347
revised have at least one intramembrane negatively charged residue (an
aspartate in putative transmembrane helix 1).
An unpublished sequence in the database (GenBank, 4 May 1998 release,
accession no. AF061335) for the S. rimosus gene
otrB (derived from strain M15883 [1]) is,
in its entirety, identical to nt 290 to 1840 of our revised
tet347 sequence (numbering according to reference
6). However, those authors presumed the translation start to be an ATG codon corresponding to our methionine 28. We favor
our upstream GTG translation start because it includes an amino-terminal cytoplasmic tail plus all of putative transmembrane helix 1 (which begins approximately at residue 23) and because our
residues 19 to 24 (FTHRQI) are identical to residues 24 to 29 of the
homologous TcrC.
We propose that "otrB" be used in the future to
designate the "tet347" gene. Our sequence of
otrB and the protein product OtrB has been deposited in
GenBank under accession no. AF079900, where nt 1 now corresponds to nt
110 of reference 6.
![]()
LETTER
Top
Letter
References
| |
ACKNOWLEDGMENTS |
|---|
We thank J. P. Reynes for plasmid pUT1954 and J. I. Rood and R. M. Kennan for their help in the initial stages of this work.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Butler, M. J., E. J. Friend, I. S. Hunter, F. S. Kaczmarek, D. A. Sugden, and M. Warren. 1989. Molecular cloning of resistance genes and architecture of a linked gene cluster involved in biosynthesis of oxytetracycline by Streptomyces rimosus. Mol. Gen. Genet. 215:231-238[Medline]. |
| 2. |
Claros, M. G., and G. von Heijne.
1994.
TopPredII: an improved software for membrane protein structure predictions.
Comput. Appl. Biosci.
10:685-686 |
| 3. | Dairi, T., K. Aisaka, R. Katsumata, and M. Hasegawa. 1995. A self-defense gene homologous to tetracycline effluxing gene essential for antibiotic production in Streptomyces aureofaciens. Biosci. Biotechnol. Biochem. 59:1835-1841[Medline]. |
| 4. |
Kennan, R. M.,
L. M. McMurry,
S. B. Levy, and J. I. Rood.
1997.
Glutamate residues located within putative transmembrane helices are essential for TetA(P)-mediated tetracycline efflux.
J. Bacteriol.
179:7011-7015 |
| 5. |
Ohnuki, T.,
T. Katch,
T. Imanaka, and S. Aiba.
1985.
Molecular cloning of tetracycline resistance genes from Streptomyces rimosus in Streptomyces griseus and characterization of the cloned genes.
J. Bacteriol.
161:1010-1016 |
| 6. | Reynes, J. P., T. Calmels, D. Drocourt, and G. Tiraby. 1988. Cloning, expression in Escherichia coli and nucleotide sequence of a tetracycline-resistance gene from Streptomyces rimosus. J. Gen. Microbiol. 134:585-598[Medline]. |
|
Laura M. McMurry Stuart B. Levy Center for Adaptation Genetics and Drug Resistance and Department of Molecular Biology and Microbiology Tufts University School of Medicine 136 Harrison Ave., Boston, MA 02111 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |